Despite significant increases of white blood cells and neutrophils, the EPO+G-CSF group did not show significant complications of vascular events such as thromboembolic accidents that might worsen primary stroke symptoms, consistent with previous reports [19,23]. This evidence concerns the gene CSF3 and stroke disorder.